KPTI - Karyopharm Therapeutics Inc.


8.77
-0.050   -0.570%

Share volume: 725,196
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%

$8.82
-0.05
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-06-2024 11-05-2024 02-19-2025 05-12-2025 08-11-2025 11-03-2025 02-13-2026
Total revenue 33.126 M 42.786 M 38.783 M 30.542 M 30.015 M 37.929 M 44.044 M 34.079 M
Cost of revenue 1.911 M 1.465 M 1.300 M 1.331 M 1.301 M 1.051 M 2.113 M 1.484 M
Gross profit 31.215 M 41.321 M 37.483 M 29.211 M 28.714 M 36.878 M 41.931 M 32.595 M
    32.38% -9.29% -22.07% -1.70% 28.43% 13.70% -22.27%  
Operating expenses 64.974 M 69.441 M 63.766 M 60.492 M 61.970 M 61.265 M 57.151 M 50.439 M
Selling general and admin 29.549 M 31.070 M 27.632 M 27.190 M 27.352 M 28.477 M 26.607 M 22.772 M
Research and development 35.425 M 38.371 M 36.134 M 33.302 M 34.618 M 32.788 M 30.544 M 27.667 M
Total expenses 64.974 M 69.441 M 63.766 M 60.492 M 61.970 M 61.265 M 57.151 M 50.439 M
    6.88% -8.17% -5.13% 2.44% -1.14% -6.72% -11.74%  
Operating income -33.759 M -28.120 M -26.283 M -31.281 M -33.256 M -24.387 M -15.220 M -17.844 M
Ebit -33.563 M -13.824 M -22.491 M -21.167 M -13.432 M -26.597 M -22.638 M -27.888 M
Pretax income -37.291 M 23.859 M -32.044 M -30.889 M -23.426 M -37.212 M -33.093 M -102.265 M
    -163.98% -234.31% -3.60% -24.16% 58.85% -11.07% 209.02%  
Income tax 71.000 K 67.000 K 28.000 K -109.000 K 36.000 K 40.000 K 34.000 K -67.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -37.362 M 23.792 M -32.072 M -30.780 M -23.462 M -37.252 M -33.127 M -102.198 M
    163.68% -234.80% 4.03% 23.78% -58.78% 11.07% -208.50%